![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:DLG3-MED12 (FusionGDB2 ID:HG1741TG9968) |
Fusion Gene Summary for DLG3-MED12 |
![]() |
Fusion gene information | Fusion gene name: DLG3-MED12 | Fusion gene ID: hg1741tg9968 | Hgene | Tgene | Gene symbol | DLG3 | MED12 | Gene ID | 1741 | 9968 |
Gene name | discs large MAGUK scaffold protein 3 | mediator complex subunit 12 | |
Synonyms | MRX|MRX90|NEDLG|PPP1R82|SAP102|XLMR | ARC240|CAGH45|FGS1|HOPA|Kto|MED12S|OHDOX|OKS|OPA1|TNRC11|TRAP230 | |
Cytomap | ('DLG3')('MED12') Xq13.1 | Xq13.1 | |
Type of gene | protein-coding | protein-coding | |
Description | disks large homolog 3discs, large homolog 3neuroendocrine-DLGprotein phosphatase 1, regulatory subunit 82synapse-associated protein 102 | mediator of RNA polymerase II transcription subunit 12CAG repeat protein 45Kohtalo homologOPA-containing proteinactivator-recruited cofactor 240 kDa componenthuman opposite pairedmediator of RNA polymerase II transcription, subunit 12 homologputati | |
Modification date | 20200313 | 20200321 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000194900, ENST00000374355, ENST00000374360, ENST00000461646, ENST00000542398, | ||
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 6 X 7 X 3=126 |
# samples | 5 | 7 | |
** MAII score | log2(5/48*10)=0.0588936890535686 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/126*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: DLG3 [Title/Abstract] AND MED12 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | DLG3(69674166)-MED12(70347743), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | DLG3-MED12 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. DLG3-MED12 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. DLG3-MED12 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. DLG3-MED12 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DLG3 | GO:0010923 | negative regulation of phosphatase activity | 19389623 |
Tgene | MED12 | GO:0006367 | transcription initiation from RNA polymerase II promoter | 12218053 |
Tgene | MED12 | GO:0045893 | positive regulation of transcription, DNA-templated | 10198638 |
Tgene | MED12 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 12037571 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BLCA | TCGA-ZF-AA51-01A | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Top |
Fusion Gene ORF analysis for DLG3-MED12 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000194900 | ENST00000462984 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
5CDS-intron | ENST00000374355 | ENST00000462984 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
5CDS-intron | ENST00000374360 | ENST00000462984 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000194900 | ENST00000333646 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000194900 | ENST00000374080 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000194900 | ENST00000374102 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000374355 | ENST00000333646 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000374355 | ENST00000374080 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000374355 | ENST00000374102 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000374360 | ENST00000333646 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000374360 | ENST00000374080 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
Frame-shift | ENST00000374360 | ENST00000374102 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-3CDS | ENST00000461646 | ENST00000333646 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-3CDS | ENST00000461646 | ENST00000374080 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-3CDS | ENST00000461646 | ENST00000374102 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-3CDS | ENST00000542398 | ENST00000333646 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-3CDS | ENST00000542398 | ENST00000374080 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-3CDS | ENST00000542398 | ENST00000374102 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-intron | ENST00000461646 | ENST00000462984 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
intron-intron | ENST00000542398 | ENST00000462984 | DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347743 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for DLG3-MED12 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347742 | + | 0.005600354 | 0.9943996 |
DLG3 | chrX | 69674166 | + | MED12 | chrX | 70347742 | + | 0.005600354 | 0.9943996 |
![]() |
![]() |
Top |
Fusion Protein Features for DLG3-MED12 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:69674166/:70347743) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for DLG3-MED12 |
![]() |
Top |
Fusion Gene PPI Analysis for DLG3-MED12 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DLG3-MED12 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for DLG3-MED12 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | DLG3 | C3501611 | Mental Retardation, X-Linked Nonsyndromic | 7 | CLINGEN |
Hgene | DLG3 | C0036341 | Schizophrenia | 5 | PSYGENET |
Hgene | DLG3 | C0005586 | Bipolar Disorder | 4 | PSYGENET |
Hgene | DLG3 | C0041696 | Unipolar Depression | 3 | PSYGENET |
Hgene | DLG3 | C1269683 | Major Depressive Disorder | 3 | PSYGENET |
Hgene | DLG3 | C0525045 | Mood Disorders | 2 | PSYGENET |
Hgene | DLG3 | C1136249 | Mental Retardation, X-Linked | 1 | CTD_human |
Hgene | DLG3 | C2931498 | Mental Retardation, X-Linked 1 | 1 | ORPHANET |
Tgene | C0036341 | Schizophrenia | 5 | PSYGENET | |
Tgene | C0220769 | FG syndrome | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C0796022 | Lujan Fryns syndrome | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C0006142 | Malignant neoplasm of breast | 2 | CTD_human | |
Tgene | C0011570 | Mental Depression | 2 | PSYGENET | |
Tgene | C0011581 | Depressive disorder | 2 | PSYGENET | |
Tgene | C0033578 | Prostatic Neoplasms | 2 | CTD_human | |
Tgene | C0206650 | Fibroadenoma | 2 | CTD_human | |
Tgene | C0376358 | Malignant neoplasm of prostate | 2 | CTD_human | |
Tgene | C0678222 | Breast Carcinoma | 2 | CTD_human | |
Tgene | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human | |
Tgene | C1458155 | Mammary Neoplasms | 2 | CTD_human | |
Tgene | C3698541 | Ohdo syndrome, Maat-Kievit-Brunner type | 2 | GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human | |
Tgene | C0010701 | Phyllodes Tumor | 1 | CTD_human | |
Tgene | C0019569 | Hirschsprung Disease | 1 | GENOMICS_ENGLAND | |
Tgene | C0033975 | Psychotic Disorders | 1 | PSYGENET | |
Tgene | C0041696 | Unipolar Depression | 1 | PSYGENET | |
Tgene | C0206686 | Adrenocortical carcinoma | 1 | CTD_human | |
Tgene | C0349204 | Nonorganic psychosis | 1 | PSYGENET | |
Tgene | C0600066 | Malignant Cystosarcoma Phyllodes | 1 | CTD_human | |
Tgene | C1269683 | Major Depressive Disorder | 1 | PSYGENET | |
Tgene | C1845546 | FG SYNDROME 4 (disorder) | 1 | CTD_human | |
Tgene | C1845567 | FG SYNDROME 3 | 1 | CTD_human | |
Tgene | C1845902 | FG SYNDROME 2 | 1 | CTD_human | |
Tgene | C3495676 | Anorectal Malformations | 1 | GENOMICS_ENGLAND | |
Tgene | C3888239 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 1 | GENOMICS_ENGLAND | |
Tgene | C4551487 | Submucous cleft palate | 1 | GENOMICS_ENGLAND |